Article
FDA approves Moderna's mRNA flu vaccine after initial pushback
Bearish
-55.0
−100 Bearish
0
+100 Bullish
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bearish
-55.0
−100Neutral+100
More Like This